Compare · MTD vs TMO
MTD vs TMO
Side-by-side comparison of Mettler-Toledo International Inc. (MTD) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both companies sit in the Industrials sector. MTD focuses on Biotechnology: Laboratory Analytical Instruments, while TMO focuses on Industrial Machinery/Components.
- TMO is the larger of the two at $174.30B, about 6.8x MTD ($25.66B).
- Over the past year, MTD is up 14.9% and TMO is up 10.7% - MTD leads by 4.1 points.
- TMO has been more active in the news (10 items in the past 4 weeks vs 3 for MTD).
- TMO has more recent analyst coverage (25 ratings vs 22 for MTD).
- Company
- Mettler-Toledo International Inc.
- Thermo Fisher Scientific Inc
- Price
- $1270.32-0.57%
- $469.06-2.15%
- Market cap
- $25.66B
- $174.30B
- 1M return
- -0.36%
- -5.16%
- 1Y return
- +14.89%
- +10.74%
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- 1997
- News (4w)
- 3
- 10
- Recent ratings
- 22
- 25
Mettler-Toledo International Inc.
Mettler-Toledo International Inc. manufactures and supplies precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; various related analytical instruments and automated chemistry solutions used in drug and chemical compound discovery and development; metal detection and other end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries; and solutions that are used in various process analytics applications. Its laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform. The company's industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, and product inspection systems. Its retail weighing solutions consist of networked scales and software, and stand-alone scales for handling fresh goods, such as meats, vegetables, fruits, and cheeses. The company serves the life science industry, and independent research organizations; food and beverage producers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community. It markets its products through its direct sales force and indirect distribution channels. The company was incorporated in 1991 and is based in Columbus, Ohio.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest MTD
- Mettler-Toledo International Inc. Announces Webcast of Presentation at the BofA Securities 2026 Healthcare Conference
- Mettler-Toledo International Inc. to Host First Quarter 2026 Earnings Conference Call
- Teleflex Announces Governance Updates
- Amendment: SEC Form SCHEDULE 13G/A filed by Mettler-Toledo International Inc.
- Mettler-Toledo upgraded by Jefferies with a new price target
- SEC Form DEFA14A filed by Mettler-Toledo International Inc.
- SEC Form DEF 14A filed by Mettler-Toledo International Inc.
- Director Tokich Michael J was granted 50 shares (SEC Form 4)
- SEC Form SCHEDULE 13G filed by Mettler-Toledo International Inc.
- Chief Financial Officer Vadala Shawn exercised 800 shares at a strike of $595.31 and sold $1,128,096 worth of shares (800 units at $1,410.12) (SEC Form 4)
Latest TMO
- SEC Form 10-Q filed by Thermo Fisher Scientific Inc
- President & COO Pettiti Gianluca sold $185,064 worth of shares (400 units at $462.66) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 25,051 units (SEC Form 4)
- Thermo Fisher Scientific to Host Investor Day
- Thermo Fisher Scientific Signs Agreement to Sell its Microbiology Business to Astorg
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Thermo Fisher Scientific Reports First Quarter 2026 Results
- AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages
- Thermo Fisher Scientific Expands Global Biobank Leadership Through Strategic Collaboration with PRECISE-SG100K Singapore to Advance Population-Scale Proteomics
- SEC Form DEFA14A filed by Thermo Fisher Scientific Inc
- SEC Form DEF 14A filed by Thermo Fisher Scientific Inc